165 related articles for article (PubMed ID: 12372098)
1. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma.
Leman JA; Dick DC; Morton CA
Clin Exp Dermatol; 2002 Sep; 27(6):516-8. PubMed ID: 12372098
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Orenstein A; Haik J; Tamir J; Winkler E; Trau H; Malik Z; Kostenich G
Dermatol Surg; 2000 Aug; 26(8):765-9; discussion 769-70. PubMed ID: 10940064
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy may be useful in debulking cutaneous lymphoma prior to radiotherapy.
Umegaki N; Moritsugu R; Katoh S; Harada K; Nakano H; Tamai K; Hanada K; Tanaka M
Clin Exp Dermatol; 2004 Jan; 29(1):42-5. PubMed ID: 14723720
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.
Zane C; Venturini M; Sala R; Calzavara-Pinton P
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):254-8. PubMed ID: 16948827
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma.
Salva KA; Kim YH; Rahbar Z; Wood GS
Photochem Photobiol; 2018 Sep; 94(5):1058-1065. PubMed ID: 29675945
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
7. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
8. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer.
Ibbotson SH
Br J Dermatol; 2002 Feb; 146(2):178-88. PubMed ID: 11903225
[TBL] [Abstract][Full Text] [Related]
9. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy: current evidence and applications in dermatology.
Lee Y; Baron ED
Semin Cutan Med Surg; 2011 Dec; 30(4):199-209. PubMed ID: 22123417
[TBL] [Abstract][Full Text] [Related]
12. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.
Morton CA; Whitehurst C; Moore JV; MacKie RM
Br J Dermatol; 2000 Oct; 143(4):767-72. PubMed ID: 11069454
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
[TBL] [Abstract][Full Text] [Related]
14. Topical photodynamic therapy is immunosuppressive in humans.
Matthews YJ; Damian DL
Br J Dermatol; 2010 Mar; 162(3):637-41. PubMed ID: 19863500
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
16. PHOTODYNAMIC TREATMENT WITH NANOEMULSIFIED 5-AMINOLEVULINIC ACID AND NARROW BAND RED LIGHT FOR FIELD CANCERIZATION DUE TO OCCUPATIONAL EXPOSURE TO ULTRAVIOLET LIGHT IRRADIATION.
Wollina U; Gaber B; Koch A
Georgian Med News; 2018 Jan; (274):138-143. PubMed ID: 29461242
[TBL] [Abstract][Full Text] [Related]
17. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
[TBL] [Abstract][Full Text] [Related]
18. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
[TBL] [Abstract][Full Text] [Related]
19. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
20. Plum-blossom needling enhanced the effect of photodynamic therapy on basal cell carcinoma.
Mu X; Wang L; Wang L; Ge R; Dang H; Mou K
Photodiagnosis Photodyn Ther; 2018 Sep; 23():339-341. PubMed ID: 30077651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
